Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers

Class I MHC tetramers allow direct phenotypic identification of CD8+ T cell populations, but their production remains laborious. A peptide exchange strategy that employs class I MHC products loaded with conditional ligands (caged MHC molecules) provides a fast and straightforward method to obtain diverse arrays of class I MHC tetramers and facilitates CD8+ T cell epitope discovery. Here, we describe the development of photocleavable analogs of the FAPGNYPAL (SV9) epitope that bind H-2Kb and H-2Db with full retention of their structural and functional integrity. We ranked all possible H-2Kb octameric and H-2Db nonameric epitopes that span the genome of Chlamydia trachomatis and prepared MHC tetramers from ≈2,000 of the highest scoring peptides by replacement of the SV9 analog with the peptide of choice. The resulting 2,000-member class I MHC tetramer array allowed the discovery of two variants of an epitope derived from polymorphic membrane protein I (PmpI) and an assessment of the kinetics of emergence and the effector function of the corresponding CD8+ T cells.

[1]  J. Ortaldo,et al.  Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells. , 1977, Journal of the National Cancer Institute.

[2]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[3]  R. Rank,et al.  Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines , 1991, Infection and immunity.

[4]  Hidde L. Ploegh,et al.  Peptide selection by MHC class I molecules , 1991, Nature.

[5]  W. Kast,et al.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Wiley,et al.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. A. Peterson,et al.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.

[8]  P. Schatz Use of Peptide Libraries to Map the Substrate Specificity of a Peptide-Modifying Enzyme: A 13 Residue Consensus Peptide Specifies Biotinylation in Escherichia coli , 1993, Bio/Technology.

[9]  H. Ploegh,et al.  The effect of anchor residue modifications on the stability of major histocompatibility complex class I‐peptide interactions , 1993, European journal of immunology.

[10]  B. Walker,et al.  Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire , 1994, The Journal of experimental medicine.

[11]  M. Starnbach,et al.  Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. , 1994, Journal of immunology.

[12]  M. Ward The immunobiology and immunopathology of chlamydial infections , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[13]  S. Rowland-Jones,et al.  Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Madden The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.

[15]  M. Esteban,et al.  Quantification of antigen specific CD8+ T cells using an ELISPOT assay. , 1995, Journal of immunological methods.

[16]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[17]  J. Schneider-Mergener,et al.  T-cell epitope mapping by flow cytometry , 1998, Nature Medicine.

[18]  R. W. Davis,et al.  Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. , 1998, Science.

[19]  R. Dwek,et al.  Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. , 1999, Immunity.

[20]  D. Beckett,et al.  A minimal peptide substrate in biotin holoenzyme synthetase‐catalyzed biotinylation , 2008, Protein science : a publication of the Protein Society.

[21]  Ronald W. Davis,et al.  Comparative genomes of Chlamydia pneumoniae and C. trachomatis , 1999, Nature Genetics.

[22]  Guangming Zhong,et al.  Degradation of Transcription Factor Rfx5 during the Inhibition of Both Constitutive and Interferon γ–Inducible Major Histocompatibility Complex Class I Expression in Chlamydia-Infected Cells , 2000, The Journal of experimental medicine.

[23]  H. Romero,et al.  Codon usage in Chlamydia trachomatis is the result of strand-specific mutational biases and a complex pattern of selective forces. , 2000, Nucleic acids research.

[24]  M. Starnbach,et al.  CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  I. Henderson,et al.  Polymorphic proteins of Chlamydia spp.--autotransporters beyond the Proteobacteria. , 2001, Trends in microbiology.

[26]  P. Klenerman,et al.  Tracking T cells with tetramers: new tales from new tools , 2002, Nature Reviews Immunology.

[27]  N. Shastri,et al.  Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. , 2002, Annual review of immunology.

[28]  M. Starnbach,et al.  An Inclusion Membrane Protein from Chlamydia trachomatis Enters the MHC Class I Pathway and Stimulates a CD8+ T Cell Response 1 , 2003, The Journal of Immunology.

[29]  H. Zeidler,et al.  Chlamydia trachomatis-infected macrophages induce apoptosis of activated T cells by secretion of tumor necrosis factor-α in vitro , 2004, Medical Microbiology and Immunology.

[30]  T. Schumacher,et al.  MHC multimer technology: current status and future prospects. , 2005, Current opinion in immunology.

[31]  R. Brunham,et al.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.

[32]  H. Caldwell,et al.  Comparative Genomic Analysis of Chlamydia trachomatis Oculotropic and Genitotropic Strains , 2005, Infection and Immunity.

[33]  Ira Mellman,et al.  Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.

[34]  P. Skipp,et al.  Shotgun proteomic analysis of Chlamydia trachomatis , 2005, Proteomics.

[35]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[36]  M. R. Caro,et al.  Relative importance of CD4+ and CD8+ T cells in the resolution of Chlamydophila abortus primary infection in mice. , 2006, Journal of comparative pathology.

[37]  W. Bruno,et al.  Polymorphisms in the Nine Polymorphic Membrane Proteins of Chlamydia trachomatis across All Serovars: Evidence for Serovar Da Recombination and Correlation with Tissue Tropism , 2006, Journal of bacteriology.

[38]  T. Schumacher,et al.  Design and use of conditional MHC class I ligands , 2006, Nature Medicine.

[39]  T. Schumacher,et al.  Generation of peptide–MHC class I complexes through UV-mediated ligand exchange , 2006, Nature Protocols.

[40]  D. Dean,et al.  Comparative Expression Profiling of the Chlamydia trachomatis pmp Gene Family for Clinical and Reference Strains , 2007, PloS one.

[41]  Leah M. Octavio,et al.  Empty Class II Major Histocompatibility Complex Created by Peptide Photolysis Establishes the Role of DM in Peptide Association* , 2007, Journal of Biological Chemistry.